Hans-peter C. Volz
Werneck, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Effects of lavender oil preparation silexan on different symptoms of major depression - results from a randomized, controlled trial.
Journal: The international journal of neuropsychopharmacology
Published: November 28, 2025
Silexan is well-tolerated for long-term use in adults and for treatment of adolescents: a real-world data analysis.
Journal: European archives of psychiatry and clinical neuroscience
Published: December 05, 2024
Baseline symptom severity and efficacy of Silexan in patients with anxiety disorders: A symptom-based, patient-level analysis of randomized, placebo-controlled trials.
Journal: European psychiatry : the journal of the Association of European Psychiatrists
Published: March 01, 2024
Lavender oil preparation Silexan is effective in mild-to-moderate major depression: a randomized, placebo- and reference-controlled trial.
Journal: European archives of psychiatry and clinical neuroscience
Published: December 29, 2023
Psychiatric manifestations of post-COVID-19 syndrome: the potential benefit of Silexan.
Journal: International journal of psychiatry in clinical practice
Published: April 06, 2023
Effect of anxiolytic drug silexan on sleep - a narrative review.
Journal: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
Published: October 19, 2022
Factors associated with sick leave duration in patients suffering from major depressive disorder initiating antidepressant treatment: a real-world evidence study in Germany and Spain.
Journal: International journal of psychiatry in clinical practice
Published: July 08, 2022
Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomized, placebo-controlled trials.
Journal: European archives of psychiatry and clinical neuroscience
Published: July 07, 2022
Subthreshold depression - concept, operationalisation and epidemiological data. A scoping review.
Journal: International journal of psychiatry in clinical practice
Published: June 23, 2022
Sick leave duration as a potential marker of functionality and disease severity in depression.
Journal: International journal of psychiatry in clinical practice
Published: April 04, 2022
Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited.
Journal: European archives of psychiatry and clinical neuroscience
Published: December 02, 2021
Predictors of sick leave days in patients affected by major depressive disorder receiving antidepressant treatment in general practice setting in Germany.
Journal: International journal of psychiatry in clinical practice
Published: September 20, 2021
Last Updated: 09/26/2026